CGRP Inhibitors Market

Market Study on CGRP inhibitors: Flooding Investments in R&D, and Technological Advancements in Acute Migraine Treatment Promise a Host of Revenue Generation Opportunities for Active Participants in the CGRP inhibitors market.

A Detailed Analysis of the CGRP Inhibitors Market Based on the Remarkably Increasing Awareness Regarding Signs, Symptoms, and Treatment of Migraine

Report ID: PMRREP33710

Number of Pages: 213

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Published Date: January-2024

Report Price

$4900*

Buy Now

Table of Content

1. Executive Summary

    1.1. Global CGRP Inhibitors Market Snapshot, 2023 and 2030

    1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events   

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Challenges

        2.2.5. Key Trends

    2.3. Molecule Lifecycle Analysis

    2.4. CGRP Inhibitors Market: Value Chain

        2.4.1. List of Raw Material Supplier

        2.4.2. List of Manufacturers

        2.4.3. List of Distributors

        2.4.4. List of Applications

        2.4.5. Profitability Analysis

    2.5. Porter Five Force's Analysis

    2.6. Geopolitical Tensions: Market Impact   

    2.7. Macro-Economic Factors

        2.7.1. Global Sectorial Outlook

        2.7.2. Global GDP Growth Outlook

        2.7.3. Global Parent Market Overview

    2.8. Forecast Factors - Relevance and Impact

    2.9. Regulatory and Technology Landscape

3. Global CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    3.1. Key Highlights

        3.1.1. Market Volume (Units) Projections

        3.1.2. Market Size and Y-o-Y Growth

        3.1.3. Absolute $ Opportunity

    3.2. Market Size (US$ Mn) Analysis and Forecast

        3.2.1. Historical Market Size Analysis, 2013-2016

        3.2.2. Current Market Size Forecast, 2018-2026

    3.3. Global CGRP Inhibitors Market Outlook: Molecule

        3.3.1. Introduction / Key Findings

        3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Molecule, 2018 - 2022

        3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

            3.3.3.1. Small Molecule

            3.3.3.2. Large Molecule

    3.4. Market Attractiveness Analysis: Molecule

    3.5. Global CGRP Inhibitors Market Outlook: Treatment

        3.5.1. Introduction / Key Findings

        3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment, 2018 - 2022

        3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

            3.5.3.1. Preventive Migraine Treatment

            3.5.3.2. Acute Migraine Treatment

    3.6. Market Attractiveness Analysis: Treatment

    3.7. Global CGRP Inhibitors Market Outlook: Route of Administration

        3.7.1. Introduction / Key Findings

        3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2018 - 2022

        3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

            3.7.3.1. Oral

            3.7.3.2. Nasal

            3.7.3.3. Injectables

    3.8. Market Attractiveness Analysis: Route of Administration

    3.9. Global CGRP Inhibitors Market Outlook: End User

        3.9.1. Introduction / Key Findings

        3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022

        3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

            3.9.3.1. Hospitals

            3.9.3.2. Specialty clinics

            3.9.3.3. Mail order pharmacies

            3.9.3.4. Retail Pharmacies

    3.10. Market Attractiveness Analysis: End User

4. Global CGRP Inhibitors Market Outlook: Region

    4.1. Key Highlights

    4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022

    4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030

        4.3.1. North America

        4.3.2. Europe

        4.3.3. East Asia

        4.3.4. South Asia & Pacific

        4.3.5. Latin America

        4.3.6. Middle East & Africa (MEA)

    4.4. Market Attractiveness Analysis: Region

5. North America CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030) 

    5.1. Key Highlights

    5.2. Pricing Analysis

    5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        5.3.1. By Country

        5.3.2. By Molecule

        5.3.3. By Treatment

        5.3.4. By Route of Administration 

        5.3.5. By End User

    5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        5.4.1. U.S.

        5.4.2. Canada

    5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

        5.5.1. Small Molecule

        5.5.2. Large Molecule

    5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

        5.6.1. Preventive Migraine Treatment

        5.6.2. Acute Migraine Treatment

    5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        5.7.1. Oral

        5.7.2. Nasal

        5.7.3. Injectables

    5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        5.8.1. Hospitals

        5.8.2. Specialty clinics

        5.8.3. Mail order pharmacies 

        5.8.4. Retail Pharmacies

    5.9. Market Attractiveness Analysis

6. Europe CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    6.1. Key Highlights

    6.2. Pricing Analysis

    6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        6.3.1. By Country

        6.3.2. By Molecule

        6.3.3. By Treatment

        6.3.4. By Route of Administration 

        6.3.5. By End User

    6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        6.4.1. Germany

        6.4.2. France

        6.4.3. U.K.

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Russia

        6.4.7. Turkey

        6.4.8. Rest of Europe

    6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

        6.5.1. Small Molecule

        6.5.2. Large Molecule

    6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

        6.6.1. Preventive Migraine Treatment

        6.6.2. Acute Migraine Treatment

    6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        6.7.1. Oral

        6.7.2. Nasal

        6.7.3. Injectables

    6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        6.8.1. Hospitals

        6.8.2. Specialty clinics

        6.8.3. Mail order pharmacies 

        6.8.4. Retail Pharmacies

    6.9. Market Attractiveness Analysis

7. East Asia CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    7.1. Key Highlights

    7.2. Pricing Analysis

    7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        7.3.1. By Country

        7.3.2. By Molecule

        7.3.3. By Treatment

        7.3.4. By Route of Administration 

        7.3.5. By End User

    7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        7.4.1. China

        7.4.2. Japan

        7.4.3. South Korea

    7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

        7.5.1. Small Molecule

        7.5.2. Large Molecule

    7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

        7.6.1. Preventive Migraine Treatment

        7.6.2. Acute Migraine Treatment

    7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        7.7.1. Oral

        7.7.2. Nasal

        7.7.3. Injectables

    7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        7.8.1. Hospitals

        7.8.2. Specialty clinics

        7.8.3. Mail order pharmacies

        7.8.4. Retail Pharmacies

    7.9. Market Attractiveness Analysis

8. South Asia & Oceania CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    8.1. Key Highlights

    8.2. Pricing Analysis

    8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        8.3.1. By Country

        8.3.2. By Molecule

        8.3.3. By Treatment

        8.3.4. By Route of Administration 

        8.3.5. By End User

    8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        8.4.1. India

        8.4.2. Southeast Asia

        8.4.3. ANZ

        8.4.4. Rest of South Asia & Oceania

    8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

        8.5.1. Small Molecule

        8.5.2. Large Molecule

    8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

        8.6.1. Preventive Migraine Treatment

        8.6.2. Acute Migraine Treatment

    8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        8.7.1. Oral

        8.7.2. Nasal

        8.7.3. Injectables

    8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        8.8.1. Hospitals

        8.8.2. Specialty clinics

        8.8.3. Mail order pharmacies 

        8.8.4. Retail Pharmacies

    8.9. Market Attractiveness Analysis

9. Latin America CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    9.1. Key Highlights

    9.2. Pricing Analysis

    9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        9.3.1. By Country

        9.3.2. By Molecule

        9.3.3. By Treatment

        9.3.4. By Route of Administration 

        9.3.5. By End User

    9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        9.4.1. Brazil

        9.4.2. Mexico

        9.4.3. Rest of Latin America

    9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

        9.5.1. Small Molecule

        9.5.2. Large Molecule

    9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

        9.6.1. Preventive Migraine Treatment

        9.6.2. Acute Migraine Treatment

    9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        9.7.1. Oral

        9.7.2. Nasal

        9.7.3. Injectables

    9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        9.8.1. Hospitals

        9.8.2. Specialty clinics

        9.8.3. Mail order pharmacies

        9.8.4. Retail Pharmacies

    9.9. Market Attractiveness Analysis

10. Middle East & Africa CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    10.1. Key Highlights

    10.2. Pricing Analysis

    10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        10.3.1. By Country

        10.3.2. By Molecule

        10.3.3. By Treatment

        10.3.4. By Route of Administration 

        10.3.5. By End User

    10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        10.4.1. GCC

        10.4.2. Egypt

        10.4.3. South Africa

        10.4.4. Northern Africa

        10.4.5. Rest of Middle East & Africa

    10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030

        10.5.1. Small Molecule

        10.5.2. Large Molecule

    10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030

        10.6.1. Preventive Migraine Treatment

        10.6.2. Acute Migraine Treatment

    10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        10.7.1. Oral

        10.7.2. Nasal

        10.7.3. Injectables

    10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        10.8.1. Hospitals

        10.8.2. Specialty clinics

        10.8.3. Mail order pharmacies

        10.8.4. Retail Pharmacies

    10.9. Market Attractiveness Analysis

11. Competition Landscape

    11.1. Market Share Analysis, 2022

    11.2. Market Structure

        11.2.1. Competition Intensity Mapping By Market  

        11.2.2. Competition Large Molecule

        11.2.3. Apparent Product Capacity

    11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

        11.3.1. Amgen

            11.3.1.1. Overview

            11.3.1.2. Segments and Product

            11.3.1.3. Key Financials

            11.3.1.4. Market Developments

            11.3.1.5. Market Strategy

        11.3.2. Novartis 

            11.3.2.1. Overview

            11.3.2.2. Segments and Product

            11.3.2.3. Key Financials

            11.3.2.4. Market Developments

            11.3.2.5. Market Strategy

        11.3.3. Teva Pharmaceutical Industries Ltd.

            11.3.3.1. Overview

            11.3.3.2. Segments and Product

            11.3.3.3. Key Financials

            11.3.3.4. Market Developments

            11.3.3.5. Market Strategy

        11.3.4. Eli Lilly

            11.3.4.1. Overview

            11.3.4.2. Segments and Product

            11.3.4.3. Key Financials

            11.3.4.4. Market Developments

            11.3.4.5. Market Strategy

        11.3.5. Lundbeck

            11.3.5.1. Overview

            11.3.5.2. Segments and Product

            11.3.5.3. Key Financials

            11.3.5.4. Market Developments

            11.3.5.5. Market Strategy

        11.3.6. Abbvie

            11.3.6.1. Overview

            11.3.6.2. Segments and Product

            11.3.6.3. Key Financials

            11.3.6.4. Market Developments

            11.3.6.5. Market Strategy

        11.3.7. Allergan

            11.3.7.1. Overview

            11.3.7.2. Segments and Product

            11.3.7.3. Key Financials

            11.3.7.4. Market Developments

            11.3.7.5. Market Strategy

12. Appendix

    12.1. Research Methodology

    12.2. Research Assumptions

    12.3. Acronyms and Abbreviations

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate